Table 3.
Hazard ratio | 95% confidence interval | p value | |
---|---|---|---|
Creatinine doubling (number of events N = 87) | |||
Unadjusted | 0.36 | 0.22–0.58 | < 0.001 |
Model 1 | 0.36 | 0.22–0.57 | < 0.001 |
Model 2 | 0.36 | 0.22–0.58 | < 0.001 |
Model 3 | 0.36 | 0.22–0.57 | < 0.001 |
Model 4 | 0.36 | 0.23–0.59 | < 0.001 |
Dialysis initiation (number of events N = 71) | |||
Unadjusted | 0.5 | 0.31–0.81 | 0.005 |
Model 1 | 0.5 | 0.31–0.81 | 0.005 |
Model 2 | 0.49 | 0.30–0.80 | 0.004 |
Model 3 | 0.34 | 0.20–0.56 | < 0.001 |
Model 4 | 0.28 | 0.16–0.48 | < 0.001 |
All-cause mortality (number of events N = 37) | |||
Unadjusted | 0.43 | 0.22–0.87 | 0.01 |
Model 1 | 0.43 | 0.21–0.86 | 0.018 |
Model 2 | 0.42 | 0.21–0.85 | 0.015 |
Model 3 | 0.38 | 0.18–0.77 | 0.007 |
Model 4 | 0.36 | 0.18–0.74 | 0.005 |
Model 1 adjusted for age and sex; model 2 adjusted for model 1 and demographics, body mass index, and blood pressure. Model 3: adjusted for model 2 and comorbidities (renal function. cardiovascular disease, peripheral arterial disease, diabetes, hypertension). Model 4: adjusted for model 3 and proteinuria, use of renin–angiotensin–aldosterone system inhibitors